We simultaneously knocked down IGF2BP1 and overexpressed circRRM2 in BC cells in the transwell assay, and the cell invasive ability was partially rescued (Additional file 1: Fig. S9A, B). This evidence concerns the gene IGF2BP1 and breast cancer.